# Solu Therapeutics

**Canonical:** https://apis.io/providers/solu-therapeutics/  
**Website:** https://solutherapeutics.com  
**APIs profiled:** 0

Solu Therapeutics is a clinical-stage biotechnology company headquartered in Boston, Massachusetts, pioneering a novel class of antibody therapeutics that unlock cell-surface targets by combining small molecules with effector antibodies through proprietary linker technology. Its two platform technologies are CyTAC (Cytotoxicity Targeting Chimera), which links cell-surface targets to antibodies that kill pathogenic cells, and TicTAC (Therapeutic Index Control Targeting Chimera), which gives long-acting small-molecule agonists and antagonists antibody-like pharmacokinetics. Its lead program, STX-0712, is a CyTAC targeting the GPCR CCR2 in Phase 1 trials for chronic myelomonocytic leukemia, with additional oncology and immunology programs advancing. Solu is a portfolio company of the venture firm DCVC. The company operates as a drug-discovery and clinical-development organization and publishes no public developer API, developer portal, or programmatic surface.

## Kin Score — 9.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Solu Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Therapeutics, Oncology, Immunology, Antibodies, Drug Discovery, Clinical Stage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/solu-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.